Results 11 to 20 of about 1,411,950 (341)

Data-mining of potential antitubercular activities from molecular ingredients of traditional Chinese medicines [PDF]

open access: yesPeerJ, 2014
Background. Traditional Chinese medicine encompasses a well established alternate system of medicine based on a broad range of herbal formulations and is practiced extensively in the region for the treatment of a wide variety of diseases. In recent years,
Salma Jamal   +2 more
doaj   +2 more sources

Identification of the first highly selective inhibitor of human lactate dehydrogenase B

open access: yesScientific Reports, 2021
Lactate dehydrogenase (LDH) catalyses the conversion of pyruvate to lactate and NADH to NAD+; it has two isoforms, LDHA and LDHB. LDHA is a promising target for cancer therapy, whereas LDHB is necessary for basal autophagy and cancer cell proliferation ...
Sachio Shibata   +8 more
doaj   +1 more source

UnCorrupt SMILES: a novel approach to de novo design

open access: yesJournal of Cheminformatics, 2023
Generative deep learning models have emerged as a powerful approach for de novo drug design as they aid researchers in finding new molecules with desired properties.
Linde Schoenmaker   +3 more
doaj   +1 more source

Antibiotic drug discovery [PDF]

open access: yesMicrobial Biotechnology, 2016
Summary Due to the threat posed by the increase of highly resistant pathogenic bacteria, there is an urgent need for new antibiotics; all the more so since in the last 20 years, the approval for new antibacterial agents had decreased. The field of natural product discovery has undergone a tremendous development over the past few years.
Wohlleben, Wolfgang   +3 more
openaire   +2 more sources

Computational drug discovery [PDF]

open access: yesActa Pharmacologica Sinica, 2012
Computational drug discovery is an effective strategy for accelerating and economizing drug discovery and development process. Because of the dramatic increase in the availability of biological macromolecule and small molecule information, the applicability of computational drug discovery has been extended and broadly applied to nearly every stage in ...
Si-Sheng, Ou-Yang   +5 more
openaire   +2 more sources

A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice

open access: yesScientific Reports, 2021
Accumulation of tau protein is a key pathology of age-related neurodegenerative diseases such as Alzheimer's disease and progressive supranuclear palsy. Those diseases are collectively termed tauopathies.
Tomohiro Onishi   +8 more
doaj   +1 more source

Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition

open access: yesCommunications Biology, 2021
Mimasu et al. report a rat full-length structure of kynurenine 3-monooxygenase (KMO) in its membrane-embedded form, complexed with two inhibitors. They find that the dimeric interface of KMO is critical for its activity. This study provides insights into
Shinya Mimasu   +10 more
doaj   +1 more source

Nanoscale integration of single cell biologics discovery processes using optofluidic manipulation and monitoring. [PDF]

open access: yes, 2019
The new and rapid advancement in the complexity of biologics drug discovery has been driven by a deeper understanding of biological systems combined with innovative new therapeutic modalities, paving the way to breakthrough therapies for previously ...
Chen, Ching   +17 more
core   +1 more source

Mycobacterial drug discovery

open access: yesRSC Medicinal Chemistry, 2020
Innovations in mycobacterial drug discovery to accelerate the identification of new drug candidates with confirmed targets and whole cell activity.
Katherine A. Abrahams, Gurdyal S. Besra
openaire   +3 more sources

Disruptive Strategies for Removing Drug Discovery Bottlenecks [PDF]

open access: yes, 2012
Drug Discovery is shifting focus from the industry to outside partners and in the process creating new bottlenecks, suggesting the need for a more disruptive overhaul.
Antony Williams   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy